Validation of a suite of ERP and QEEG biomarkers
Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers Written by: M. Cecchi a,*, M. Adachi
View More 
Placebo and Nocebo Response Mitigation
Empirical Strategies to Mitigate Placebo and Nocebo Effects CenExel sites are committed to enhancing understanding of the causes and implications of the placebo and nocebo effects within central nervous
View More CenExel FCR Wins Best of the Best
Tampa, Florida, July 26, 2023 /GlobeNewswire/ — CenExel FCR has been named the 2023 Tampa Bay Times People’s Choice, Best of the Best in Clinical Research. This remarkable achievement
View More Stuart Goldblatt Joins CenExel as CEO
Salt Lake City, July 17, 2023 /GlobeNewswire/ — The CenExel Board of Directors is delighted to announce that Stuart Goldblatt has joined CenExel as our new CEO effective July
View More Karuna Positive Results on Phase 3 EMERGENT-3 Trial of KarXT
CenExel is proud to announce that the work of David Walling, PhD, CEO and Principal Investigator at CenExel CNS, joined lead author, John H Krystal, as co-author of the
View More CenExel CNS Opens Center in Los Alamitos, California
[et_pb_section fb_built=”1″ _builder_version=”4.12.0″ global_colors_info=”{}”][et_pb_row _builder_version=”4.12.0″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.12.0″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″] Los Alamitos, November 29, 2022 /GlobeNewswire/ — CenExel
View More CenExel Creates Clinical Sciences Business Unit
[et_pb_section fb_built=”1″ _builder_version=”4.12.0″ global_colors_info=”{}”][et_pb_row _builder_version=”4.12.0″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.12.0″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”] Salt Lake City, November 15, 2022 /GlobeNewswire/ — CenExel announces
View More CenExel Acquires Apex Innovative Sciences
[et_pb_section fb_built=”1″ _builder_version=”4.12.0″ global_colors_info=”{}”][et_pb_row _builder_version=”4.12.0″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.12.0″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”] Salt Lake City, June 16, 2022 /GlobeNewswire/ — CenExel announces
View More CenExel Acquires iResearch
[et_pb_section fb_built=”1″ _builder_version=”3.22″ global_colors_info=”{}”][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.12.0″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″] Salt Lake City, May 3, 2022 /GlobeNewswire/ —
View More CenExel Acquires Rocky Mountain Movement Disorders Center
[et_pb_section fb_built=”1″ _builder_version=”3.22″ global_colors_info=”{}”][et_pb_row _builder_version=”3.25″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”3.27.4″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”]Salt Lake City, January 11, 2022 /GlobeNewswire/ — CenExel Clinical Research,
View More
